Fund details
A 46-year-old venture capital firm managing over $5 billion in assets, focused on investing in companies driving innovation.
Go to profile
Partners related to this fund
Greg Yap
Partner
Greg is a partner at Menlo Ventures, investing in life science and healthcare, with an emphasis on therapeutic platforms and digital health. His investments include Clear Labs, Delfi Diagnostics, and Ophelia Health. He also contributed to investments in Benchling and Recursion Pharmaceuticals.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Investment ranges
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Biotech
Consumer
Cybersecurity
Fintech
Health
Logistics
Enterprise
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
